iPierian is a biotechnology company targeting secreted Tau for treatment of Alzheimer’s disease and other Tauopathies. The company’s lead drug candidate (IPN007) is a monoclonal antibody targeting a novel form of secreted Tau that is differentially regulated in Alzheimer’s disease patients, designed to slow the spread of Tau throughout the brain and therefore inhibit the associated disease progression.
View Top Employees from iPierian| Website | http://www.ipierian.com |
| Revenue | $11.8 million |
| Funding | $58 million |
| Employees | 3 (3 on RocketReach) |
| Founded | 2007 |
| Address | 951 Gateway Blvd, South San Francisco, California 94080, US |
| Phone | (650) 872-4700 |
| Technologies |
JavaScript,
Cloudflare,
Cloudflare DNS
+2 more
(view full list)
|
| Industry | Biotechnology, Pharmaceuticals, Science and Engineering, Drug Discovery, Healthcare, Health Care, Medical Device |
| Competitors | Acorda Therapeutics, Inc., Actinobac Biomed, Inc., Brainstorm Cell Therapeutics, Neuralstem, Inc. |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular iPierian employee's phone or email?
iPierian Questions
The iPierian annual revenue was $11.8 million in 2023.
3 people are employed at iPierian.
iPierian is based in South San Francisco, California.
The NAICS codes for iPierian are [325, 3254, 32].
The SIC codes for iPierian are [28, 283].
Top iPierian Employees
Related Companies
